Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects
Clinical trial NCT03794180 · COMPLETED
Trial details
- NCT number
- NCT03794180
- Sponsor
- I-Mab Biopharma US Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2019-09-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.